Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001683168-20-002862)

Filing Details

Accession Number:: 0001683168-20-002862
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-25 19:11:45
Reporting Period:: 2020-08-24

Accepted Time:: 2020-08-25 19:11:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1729427	Cns Pharmaceuticals Inc.	CNSP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1705978	Christopher Downs	C/O Cns Pharmaceuticals, Inc. 2100 West Loop South, Suite 900 Houston TX 77027	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-24	142,000	$2.04	142,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $1.84 to $2.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.